Literature DB >> 28192398

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

C Dozier1,2, L Mazzolini1,2, C Cénac1, C Froment3, O Burlet-Schiltz3, A Besson1, S Manenti1,2.   

Abstract

The phosphatase CDC25A is a key regulator of cell cycle progression by dephosphorylating and activating cyclin-CDK complexes. CDC25A is an unstable protein expressed from G1 until mitosis. CDC25A overexpression, which can be caused by stabilization of the protein, accelerates the G1/S and G2/M transitions, leading to genomic instability and promoting tumorigenesis. Thus, controlling CDC25A protein levels by regulating its stability is a critical mechanism for timing cell cycle progression and to maintain genomic integrity. Herein, we show that CDC25A is phosphorylated on Ser40 throughout the cell cycle and that this phosphorylation is established during the progression from G1 to S phase. We demonstrate that CyclinD-CDK4/CDK6 complexes mediate the phosphorylation of CDC25A on Ser40 during G1 and that these complexes directly phosphorylate this residue in vitro. Importantly, we also find that CyclinD1-CDK4 decreases CDC25A stability in a ßTrCP-dependent manner and that Ser40 and Ser88 phosphorylations contribute to this regulation. Thus our results identify cyclinD-CDK4/6 complexes as novel regulators of CDC25A stability during G1 phase, generating a negative feedback loop allowing control of the G1/S transition.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28192398     DOI: 10.1038/onc.2016.506

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase.

Authors:  James R A Hutchins; Paul R Clarke
Journal:  Cell Cycle       Date:  2004-01       Impact factor: 4.534

2.  Cell cycling through Cdc25A: transducer of cytokine proliferative signals.

Authors:  C Kittipatarin; W Q Li; D V Bulavin; S K Durum; A R Khaled
Journal:  Cell Cycle       Date:  2006-05-01       Impact factor: 4.534

Review 3.  CDC25A: a rebel within the CDC25 phosphatases family?

Authors:  Anne Fernandez-Vidal; Anne Mazars; Stéphane Manenti
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

4.  Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

Authors:  H Watanabe; Z Q Pan; N Schreiber-Agus; R A DePinho; J Hurwitz; Y Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction.

Authors:  Y Honaker; H Piwnica-Worms
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

6.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

7.  Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Hiroyuki Hirai; Evan C Osmundson; Xianghong Zou; Roberta Franks; Konstantin Christov; Hiroaki Kiyokawa
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

8.  Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity.

Authors:  Alexander P Ducruet; John S Lazo
Journal:  J Biol Chem       Date:  2003-06-11       Impact factor: 5.157

9.  Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.

Authors:  Luca Busino; Maddalena Donzelli; Massimo Chiesa; Daniele Guardavaccaro; Dvora Ganoth; N Valerio Dorrello; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  Nature       Date:  2003-11-06       Impact factor: 49.962

10.  Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.

Authors:  I Hoffmann; G Draetta; E Karsenti
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  15 in total

1.  MAP9 Exhibits Protumor Activities and Immune Escape toward Bladder Cancer by Mediating TGF-β1 Pathway.

Authors:  Chong Zhang; Bing Han; Yuanyuan Guo; Han Guan; Zhijun Chen; Beibei Liu; Wenyan Sun; Wenyong Li; Wei Sun; Sheng Wang
Journal:  J Oncol       Date:  2022-05-24       Impact factor: 4.501

2.  ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway.

Authors:  Shuai Zhu; Zhenzhou Xu; Yong Zeng; Ying Long; Gang Fan; Qi Ding; Yuheng Wen; Jian Cao; Tao Dai; Weiqing Han; Yu Xie
Journal:  Front Oncol       Date:  2020-11-09       Impact factor: 6.244

3.  SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

Authors:  Wenguang Liu; Manwu Wu; Hechun Du; Xiaoliang Shi; Tao Zhang; Jie Li
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

4.  Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer.

Authors:  Yong-Jie Hu; Wen-Wen Sun; Tong-Chao Zhao; Ying Liu; Dong-Wang Zhu; Li-Zhen Wang; Jiang Li; Chen-Ping Zhang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

5.  [Expression of CDC25A in non-small cell lung cancer and its relationship with let-7 gene].

Authors:  Dianming Li; Zhaofei Liu; Guolan Ning
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

6.  Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.

Authors:  Lanfang Jiang; Zitong Zhao; Leilei Zheng; Liyan Xue; Qimin Zhan; Yongmei Song
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-06-09       Impact factor: 7.691

7.  Lupeol inhibits growth and migration in two human colorectal cancer cell lines by suppression of Wnt-β-catenin pathway.

Authors:  Yihao Wang; Dan Hong; Yuqin Qian; Xuezi Tu; Keke Wang; Xianhong Yang; Sijia Shao; Xinlong Kong; Zhefeng Lou; Longjin Jin
Journal:  Onco Targets Ther       Date:  2018-11-09       Impact factor: 4.147

8.  Coupling function of cyclin-dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma.

Authors:  Chenzhou Xu; Wei Zhang; Xuening Zhang; Danhua Zhou; Lishuai Qu; Jinxia Liu; Mingbing Xiao; Runzhou Ni; Feng Jiang; Wenkai Ni; Cuihua Lu
Journal:  Cancer Sci       Date:  2018-12-26       Impact factor: 6.716

9.  Silencing CDC25A inhibits the proliferation of liver cancer cells by downregulating IL‑6 in vitro and in vivo.

Authors:  Si Chen; Yanping Tang; Chun Yang; Kezhi Li; Xiaoqing Huang; Ji Cao
Journal:  Int J Mol Med       Date:  2020-01-09       Impact factor: 4.101

10.  Standardized Saponin Extract from Baiye No.1 Tea (Camellia sinensis) Flowers Induced S Phase Cell Cycle Arrest and Apoptosis via AKT-MDM2-p53 Signaling Pathway in Ovarian Cancer Cells.

Authors:  Youying Tu; Lianfu Chen; Ning Ren; Bo Li; Yuanyuan Wu; Gary O Rankin; Yon Rojanasakul; Yaomin Wang; Yi Charlie Chen
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.